<DOC>
	<DOC>NCT00667225</DOC>
	<brief_summary>The University of North Carolina Department of Dermatology is conducting a clinical trial to evaluate a drug called cantharidin in the treatment of molluscum contagiosum. Molluscum is a common dermatologic disorder caused by a poxvirus. Molluscum typically presents with many flesh-colored bumps on the skin. It goes away on its own, though can last several months to several years. Cantharidin is a topical medicine which is applied at the clinic visit. It is well tolerated by the majority of children.</brief_summary>
	<brief_title>Efficacy of Cantharidin in Molluscum Contagiosum</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Molluscum Contagiosum</mesh_term>
	<mesh_term>Cantharidin</mesh_term>
	<criteria>Anyone aged 510 years with the clinical diagnosis of molluscum contagiosum. Anyone with immunosuppression including HIV or previous organ transplantation. Anyone taking immunosuppressive medications. Anyone who has previously received treatment with cantharidin. Any female who has had her first menstrual period.</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>